Cynata Therapeutics Ltd

51S

Company Profile

  • Business description

    Cynata Therapeutics Ltd is an Australian stem cell and regenerative medicine company pioneering a revolutionary approach to cell therapy with its proprietary Cymerus platform technology. The company operates in one business segment, namely the development and commercialisation of therapeutic products.

  • Contact

    100 Cubitt Street
    Level 3
    CremorneVIC3121
    AUS

    T: +61 370676940

    https://www.cynata.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    2

Stocks News & Analysis

stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.
stocks

Investor Playbook: Can your portfolio handle what’s next?

Testing portfolio resilience in an uncertain market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,179.8024.70-0.27%
CAC 408,368.917.550.09%
DAX 4026,749.9521.93-0.08%
Dow JONES (US)52,347.5550.460.10%
FTSE 10010,902.5639.470.36%
HKSE23,808.00170.400.72%
NASDAQ25,136.27229.82-0.91%
Nikkei 22559,891.141,251.21-2.05%
NZX 50 Index14,303.77130.090.92%
S&P 5007,561.6730.73-0.40%
S&P/ASX 2009,058.1024.10-0.27%
SSE Composite Index3,610.7523.60-0.65%

Market Movers